⌘K

Login Start Free

Home/Filings/4/0001727809-26-000002

4//SEC Filing

Harsch Mutya 4

Accession 0001727809-26-000002

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 8:30 AM ET

Size

5.1 KB

Accession

0001727809-26-000002

Insider Transaction Report

Form 4

Period: 2025-12-31

VYNE Therapeutics Inc.VYNE

CHIEF LEGAL OFFICER AND GC

Transactions

Tax Payment
Common Stock
2025-12-31$0.58/sh−3,579$2,076→ 125,905 total

Footnotes (1)

[F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file

4
form4-01052026_080101.xmlPrimary

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1

filerCIK 0001727809

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 8:30 AM ET
Size: 5.1 KB

View on SEC.gov